Sino Biological (SZSE:301047) FCF Margin % : 79.10% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Sino Biological FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sino Biological's Free Cash Flow for the three months ended in Dec. 2023 was ¥134.7 Mil. Sino Biological's Revenue for the three months ended in Dec. 2023 was ¥170.3 Mil. Therefore, Sino Biological's FCF Margin % for the quarter that ended in Dec. 2023 was 79.10%.

As of today, Sino Biological's current FCF Yield % is -7.87%.

The historical rank and industry rank for Sino Biological's FCF Margin % or its related term are showing as below:

SZSE:301047' s FCF Margin % Range Over the Past 10 Years
Min: -111.51 Med: 8.67 Max: 67.32
Current: -111.51

During the past 7 years, the highest FCF Margin % of Sino Biological was 67.32%. The lowest was -111.51%. And the median was 8.67%.

SZSE:301047's FCF Margin % is ranked better than
53.58% of 1034 companies
in the Biotechnology industry
Industry Median: -148.935 vs SZSE:301047: -111.51

Sino Biological FCF Margin % Historical Data

The historical data trend for Sino Biological's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biological FCF Margin % Chart

Sino Biological Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

4.51

67.32

61.61

16.24

-111.51

Sino Biological Quarterly Data
	Dec17	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															20.63	-96.76	-537.01	12.52	79.10

Competitive Comparison of Sino Biological's FCF Margin %

For the Biotechnology subindustry, Sino Biological's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sino Biological's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biological's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sino Biological's FCF Margin % falls into.

Sino Biological FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sino Biological's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-720.796	/	646.389
	=	-111.51 %

Sino Biological's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	134.737	/	170.327
	=	79.10 %

Sino Biological FCF Margin % Related Terms

Thank you for viewing the detailed overview of Sino Biological's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biological (SZSE:301047) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biological Inc (SZSE:301047) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 Kechuang 10th Street, Room 306, Building 9, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176

Website

https://www.sinobiological.com

Sino Biological Inc is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.

Sino Biological (SZSE:301047) Headlines

No Headlines